Related references
Note: Only part of the references are listed.Combined Immunohistochemistry after Mass Spectrometry Imaging for Superior Spatial Information
Katharina Kriegsmann et al.
PROTEOMICS CLINICAL APPLICATIONS (2019)
Evaluation of anticancer activity of α-defensins purified from neutrophils trapped in leukoreduction filters
Shirin Ferdowsi et al.
LIFE SCIENCES (2019)
Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: A mathematical model
Yangjin Kim et al.
PLOS ONE (2019)
Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
Edward B. Garon et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Neutrophil Heterogeneity in Cancer: From Biology to Therapies
Pacome Lecot et al.
FRONTIERS IN IMMUNOLOGY (2019)
MALDI Mass Spectrometry Imaging Linked with Top-Down Proteomics as a Tool to Study the Non-Small-Cell Lung Cancer Tumor Microenvironment
Eline Berghmans et al.
METHODS AND PROTOCOLS (2019)
Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance
Zhenqing Ye et al.
CLINICAL CANCER RESEARCH (2018)
Atezolizumab: A Review in Previously Treated Advanced Non-Small Cell Lung Cancer
Hannah A. Blair
TARGETED ONCOLOGY (2018)
Reproducible proteomics sample preparation for single FFPE tissue slices using acid-labile surfactant and direct trypsinization
Melanie Christine Foell et al.
CLINICAL PROTEOMICS (2018)
Predictive Biomarkers for Checkpoint Immunotherapy: Current Status and Challenges for Clinical Application
Nancy Tray et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity
Purnima Bhat et al.
CELL DEATH & DISEASE (2017)
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma
Ricardo E. Vilain et al.
CLINICAL CANCER RESEARCH (2017)
Programmed Cell Death 1 (PD-1) Ligand (PD-L1) Expression in Solid Tumors As a Predictive Biomarker of Benefit From PD-1/PD-L1 Axis Inhibitors: A Systematic Review and Meta-Analysis
Monica Khunger et al.
JCO PRECISION ONCOLOGY (2017)
Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma
Adil I. Daud et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics
Diana Gaspar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Cardinal: an R package for statistical analysis of mass spectrometry-based imaging experiments
Kyle D. Bemis et al.
BIOINFORMATICS (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
ProSight Lite: Graphical software to analyze top-down mass spectrometry data
Ryan T. Fellers et al.
PROTEOMICS (2015)
Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer
Julie Jacobs et al.
ONCOTARGET (2015)
Nivolumab in melanoma: latest evidence and clinical potential
Douglas B. Johnson et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)
MALDI TOF imaging mass spectrometry in clinical pathology: A valuable tool for cancer diagnostics
Joerg Kriegsmann et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Assays for predicting and monitoring responses to lung cancer immunotherapy
Cristina Teixido et al.
CANCER BIOLOGY & MEDICINE (2015)
Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis
Katja Hattar et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
MALDI-TOF MS as evolving cancer diagnostic tool: A review
Miguel Angel Merlos Rodrigo et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Programmed death ligand-1 expression in non-small cell lung cancer
Vamsidhar Velcheti et al.
LABORATORY INVESTIGATION (2014)
Sample Preparation Strategies for Mass Spectrometry Imaging of 3D Cell Culture Models
Dorothy R. Ahlf Wheatcraft et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
New modalities of cancer treatment for NSCLC: focus on immunotherapy
Marianne Davies
CANCER MANAGEMENT AND RESEARCH (2014)
Large-scale Identification of Endogenous Secretory Peptides Using Electron Transfer Dissociation Mass Spectrometry
Kazuki Sasaki et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Optimization of Electron Transfer Dissociation via Informed Selection of Reagents and Operating Parameters
Philip D. Compton et al.
ANALYTICAL CHEMISTRY (2012)
Electron Transfer Dissociation (ETD) of Peptides Containing Intrachain Disulfide Bonds
Scott R. Cole et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Linking Mass Spectrometric Imaging and Traditional Peptidomics: A Validation in the Obese Mouse Model
L. Minerva et al.
ANALYTICAL CHEMISTRY (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry
Rita Casadonte et al.
NATURE PROTOCOLS (2011)
Mass Spectrometric Imaging for Biomedical Tissue Analysis
Kamila Chughtai et al.
CHEMICAL REVIEWS (2010)
Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation
Joshua A. Bauer et al.
CLINICAL CANCER RESEARCH (2010)
Mass Spectrometric Determination of Disulfide Linkages in Recombinant Therapeutic Proteins Using Online LC-MS with Electron-Transfer Dissociation
Shiaw-Lin Wu et al.
ANALYTICAL CHEMISTRY (2009)
Human Neutrophil Peptides 1-3-Early markers in development of colorectal adenomas and carcinomas
Henning Mothes et al.
DISEASE MARKERS (2008)
Human alpha-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice
Ning Xu et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Direct profiling and identification of peptide expression differences in the pancreas of control and ob/ob mice by imaging mass spectrometry
Laurens Minerva et al.
PROTEOMICS (2008)
Proteomics as a tool for biomarker discovery
Elise C. Kohn et al.
DISEASE MARKERS (2007)
Antigen-epitope retrieval to facilitate proteomic analysis of formalin-fixed archival brain tissue
F. Rahimi et al.
ANALYTICAL CHEMISTRY (2006)
Identification of formaldehyde-induced modifications in proteins: Reactions with insulin
Bernard Metz et al.
BIOCONJUGATE CHEMISTRY (2006)
The role of antimicrobial peptides in innate immunity
T Ganz
INTEGRATIVE AND COMPARATIVE BIOLOGY (2003)
Raised plasma concentrations of α-defensins in patients with idiopathic pulmonary fibrosis
H Mukae et al.
THORAX (2002)
Human α-defensins HNPs-1,-2, and-3 in renal cell carcinoma -: Influences on tumor cell proliferation
CA Müller et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues
M Stoeckli et al.
NATURE MEDICINE (2001)
Share Paper
